Barclays’s Medidata Solutions, Inc. MDSO Stock Holding History

Barclays’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,000	Closed	-$183K	–	7172
2019 Q3	$183K	Hold	2,000	–	–	﹤0.01%	5039
2019 Q2	$181K	Buy	+2,000	New	+$176K	﹤0.01%	5210
2019 Q1	–	Sell	-6,900	Closed	-$465K	–	7543
2018 Q4	$465K	Buy	+6,900	New	+$487K	﹤0.01%	3877

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Barclays's MDSO Position: Q4 2019 in Review

Barclays sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 486,514 shares — an estimated $44.5M sold.

Barclays first reported a position in MDSO in Q2 2013 and held it in 26 quarters. The position peaked at $44.5M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

Barclays reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
Barclays sold 486,514 Medidata Solutions, Inc. shares in Q4 2019, an estimated $44.5M.
Barclays first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 26 quarters.
Barclays's Medidata Solutions, Inc. position peaked at $44.5M in Q3 2019.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.